| Cash Flow | 2025-06-30 |
|---|---|
| Net loss | -2,705,639 |
| Stock-based compensation expense | 17,704 |
| Bad debt expense | 17,578 |
| Loss from sales of available-for-sale securities | 0 |
| Prepaid expenses and other current assets | -59,966 |
| Operating lease liability | -24,282 |
| Deferred revenue | -196,642 |
| Accrued expenses | -523,219 |
| Accounts receivable | -1,054,589 |
| Accounts payable | 117,449 |
| Depreciation of property and equipment | 34,228 |
| Amortization of internally developed software | 735,436 |
| Amortization of other intangible assets | 95,777 |
| Non-cash interest income related to accretion of discount on available-for-sale securities | 0 |
| Accounts receivable unbilled | 0 |
| Operating lease right-of-use asset | 28,976 |
| Net cash used in operating activities | -1,288,079 |
| Proceeds from sales and maturities of available-for-sale securities | 0 |
| Capitalization of internally developed software | 0 |
| Purchase of property and equipment | 454 |
| Purchase of available-for-sale securities | 0 |
| Net cash provided by (used in) investing activities | -454 |
| Payment of offering costs in connection with the on-going public offering | -1,100 |
| Payment of offering costs in connection with the issuance of common stock in connection with at the market offering agreement | 0 |
| Repurchase of common stock purchase warrants exercisable under pipe warrants | 0 |
| Proceeds from issuance of common stock in connection with at the market offering agreement | 0 |
| Net cash provided by (used in) financing activities | -1,100 |
| Net decreases in cash and cash equivalents | -1,289,633 |
iSpecimen Inc. (ISPC)
iSpecimen Inc. (ISPC)